FY29 GUIDANCE
Cupid shares rally 8% after Q2 net profit jumps 133% YoY; company raises FY27-FY29 guidance
Cupid shares surged 7.75% to Rs 381.40, hitting a 52-week high after Q2FY27 net profit jumped 133% and revenue rose 122% year-on-year. The company raised FY27–FY29 financial guidance, supported by strong domestic and international demand, expanding retail distribution, new manufacturing capacity and increased promoter and institutional shareholding.
Q2 Earnings Scorecard: Which sectors outperformed and which fell behind?
The September quarter results indicate strong revenue and profit growth in sectors like automobiles and banking. In contrast, sectors such as IT and pharmaceuticals showed weakness amid inflationary pressures. Automobile sector leaders like Maruti Suzuki and Bajaj Auto reported significant growth in sales and exports. L&T's orders surged, while the cement sector faced challenges with fluctuating prices.
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target price by 23% to Rs 12,550, citing robust CDMO business expansion, strong EBITDA margins, and a solid GLP peptide pipeline.
Divi's Labs shares jump 8% to fresh 52-week high after Q2 profit soars 64% YoY. What brokerages say after bumper results?
Divi’s Laboratories shares surged over 8% during Muhurat Trading, hitting a 52-week high after Q2 FY27 net profit jumped 64% to ₹1,127 crore. Revenue grew 35%, while brokerages differed on valuation concerns and future growth prospects.
Airtel's premiumisation push comes at a cost as net subscriber additions fall 78%
Bharti Airtel's net mobile subscriber additions plunged 78% sequentially to 7.2 lakh in the September quarter after it discontinued its Rs 299 prepaid smartphone plan, pushing churn higher. However, stronger ARPU growth to Rs 271 helped offset slower additions, supporting revenue and operating profit growth.
Titan Company shares drop 3% after Q2 results. Why Emkay, Nuvama and others remain bullish
Titan shares declined despite a 54% rise in adjusted net profit for the September quarter. Strong demand for jewellery, watches, and eyewear supported performance, while brokerages remained largely positive on the stock, citing growth prospects, market-share gains, and improving margins.
EPL Q2 Results: Profit rises 4% YoY to Rs 111 crore
EPL reported a notable 4.52% increase in net profit, reaching Rs 110.9 crore for the September quarter of FY27. With revenues from operations climbing to Rs 1,567.4 crore, a 30% year-on-year growth, the Beauty & Cosmetics and Oral Care segments played pivotal roles. Despite higher expenses, the EBITDA margins held strong above 20%. Looking forward, EPL is set to focus on sustained revenue growth and stable profit margins.
Lenskart shares rally over 10% as strong Q2 triggers target price hikes. What are Jefferies and Morgan Stanley saying?
Lenskart shares surged over 10% after the company reported a 122.1% year-on-year rise in consolidated profit to Rs 227.08 crore for the September quarter. Strong Q2 results prompted brokerages Jefferies, Morgan Stanley and Motilal Oswal to raise their target prices, citing robust revenue growth, margin expansion opportunities, competitive advantages and the company's long-term growth prospects.
ET Prime Special Series: Multibagger or IBC - Part 83: Under this auto ancillary’s hood, sales and profits tell different stories
Some auto suppliers spend years trying to win a major customer. This business has been associated with one for four decades. That has helped build manufacturing scale, product capabilities, and a presence near auto plants. But it also creates an unusual equation for investors. Nearly 90% of the company's FY26 revenue is from sales to one related customer. Its portfolio spans parts that can survive the EV transition and others more closely tied to ICE vehicles. The story is about how durable customer access becomes durable returns.
Bharat Electronics shares gain 3% as Motilal raises target price after Q2; Elara Capital upgrades to Buy
Bharat Electronics shares gained after Motilal Oswal raised its price target and Elara Capital upgraded its rating to Buy. Brokerages cited strong order visibility, healthy revenue growth and margin prospects, while delays in major defence orders remain a key risk.
Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%
Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.
SBI share price target: Jefferies, Motilal, others see up to 34% upside in state lender. Buy, sell or hold?
State Bank of India has seen a remarkable 15% increase in profits year-on-year, totaling Rs 23,038 crore for the second quarter. With a loan book surpassing Rs 52 lakh crore and a 10% rise in interest income, brokerages have set optimistic Buy ratings on SBI shares, suggesting target prices between Rs 1,225 and Rs 1,350. Despite this positive outlook, management highlighted possible obstacles from macroeconomic shifts and potential treasury losses.
Marico sees sustained growth momentum, raises FY27 margin outlook
Marico experienced significant revenue and profit growth in the September quarter due to robust demand. The company's foods and premium personal care segments led this growth, supported by reduced input costs. Marico raised its Ebitda margin outlook, anticipating continued strong demand in the future. International business performance is improving in markets such as Vietnam and the Middle East, contributing to overall growth.
Marico shares jump 6% as strong Q2 puts growth story in overdrive, sparks bullish calls
Marico reported a 31% YoY rise in Q2 FY27 net profit to Rs 550 crore, while revenue grew 12% to Rs 3,897 crore. Improved margins and strong volume growth prompted brokerages Jefferies, Systematix and Dolat Capital to maintain or upgrade Buy ratings and raise target prices, signalling optimism about growth prospects.
SaaS firm Capillary’s AI platform drives new customer wins, revenue grows 51%
Capillary’s aiRA (AI-powered Research Assistant) is an AI agent for enterprise brands that helps connect customer data across platforms and identifies opportunities to acquire, convert, retain and reactivate customers. It also executes campaigns through existing marketing tools, with human approval. It works with data from platforms such as Salesforce, Snowflake, Databricks, Google Ads and Meta, according to the investor presentation.
NTPC shares rise 3% after Q2 results. Why Jefferies and Nuvama remain bullish
NTPC shares rose after the state-owned power major reported a 14% YoY rise in standalone net profit to Rs 5,320 crore for Q2 FY27. Revenue grew 17% to Rs 45,752 crore, while EBITDA increased 9% to Rs 10,891 crore. The company also announced an interim dividend of Rs 3 per share, with November 6 set as the record date. Brokerages maintained their Buy ratings on the stock.
Shadowfax revenue rises 57% in Q2, net profit jumps fivefold
Its total revenue, including other income, rose 58% YoY to Rs 1,558 crore in Q2 FY27. The Bengaluru-based company’s total expenses rose 53% YoY to Rs 1,490 core, driven by other expenses, employee benefits expenses and depreciation and amortisation costs.
Adani Ports shares rise 3% after Q2 results. Why did Jefferies and Nomura raise target prices?
Adani Ports shares rose after the company reported strong Q2 FY27 earnings and raised its full-year guidance. Jefferies and Nomura increased their target prices, citing robust international port performance, higher earnings estimates and long-term growth prospects.
Maruti Suzuki shares see target price cuts by Jefferies, Nomura, other brokerages after Q2 net profit drops 26% YoY. What’s ahead?
Maruti Suzuki shares post marginal gains despite a 26% YoY decline in Q2 FY27 net profit. Jefferies, Nomura and Elara Capital lower their target prices, citing weaker margins and financial income, even as record sales volumes and strong revenue growth offer support.
Load More
